Figure 2
Figure 2. Outcome of CN-AML patients 60 years of age or older with respect to miR-3151 and BAALC expression. (A) Disease-free survival. (B) Overall survival.

Outcome of CN-AML patients 60 years of age or older with respect to miR-3151 and BAALC expression. (A) Disease-free survival. (B) Overall survival.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal